Skip to content

Relative potency ratio of ciprofol and propofol for unconsciousness

Relative potency ratio of ciprofol and propofol for unconsciousness

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059853
Enrollment
Unknown
Registered
2022-05-13
Start date
2022-05-06
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conditions requiring hysteroscopy

Interventions

H1:Intravenous ciprofol 0.2mg/kg
H2:Intravenous ciprofol 0.3mg/kg
H3:Intravenous ciprofol 0.4mg/kg
H4:Intravenous ciprofol 0.5mg/kg
B1:Intravenous propofol 1mg/kg
B2:Intravenous propofol 1.5mg/kg
B3:Intravenous propofol 2mg/kg
B4:Intravenous propofol 2.5mg/kg

Sponsors

Obstetrics and Gynecology Hospital Affiliated to Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective hysteroscopy; 2. 18-64 years old, BMI 18-25 kg/m2; 3. ASA physical status of ?-?.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating women; 2. There are contraindications to routine hysteroscopy; 3. Cyclopofol is contraindicated in the use of propofol; 4. A history of mental illness; 5. Complicated with severe cardiopulmonary disease; 6. Patients who are participating in other clinical studies; 7. The researchers believe that other reasons are not suitable for clinical researchers.

Design outcomes

Primary

MeasureTime frame
Does consciousness disappear;

Secondary

MeasureTime frame
Systolic blood pressure;Mean arterial pressure;Heart rate;Arterial pulse oximetry;Respiratory rate;End-tidal carbon dioxide;Entropy index;Adverse reactions;

Countries

China

Contacts

Public ContactYu Zhang

Obstetrics and Gynecology Hospital Affiliated to Zhejiang University School of Medicine

2455645947@qq.com+86 183 6818 3430

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026